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Influenza virus infection results in altered responses of human mononuclear 
leukocytes to mitogen and antigen stimulation. We have previously shown (1, 2) 
that depression of such proliferative responses to alternate (nonviral) stimuli was 
due to decreased monocyte-macrophage accessory cell function, with lymphocyte 
responsiveness preserved.  It has been unclear whether altered influenza virus- 
infected macrophage accessory cell function was due to (a) inadequate presen- 
tation of mitogens, for example,  together with class II  HLA determinants; (b) 
inadequate  production  of essential  cofactors,  notably  IL-1;  (c)  production  of 
inhibitory factors, such as IL-1  inhibitors; (d) direct cell-cell inhibition; or (e) a 
combination of such processes. The studies reported herein were undertaken to 
determine  whether  the  macrophages  produce  Ik-I  or  IL-I  inhibitors  after 
exposure to the virus. 
In addition,  production  of IL-1  and  IL-1  inhibitors by respiratory syncytial 
virus (RSV)l-exposed human macrophages was examined. In contrast to influenza 
virus,  infections  with  RSV  commonly  recur,  despite  serological  evidence  of 
immunity of the individual and the lack of clear evidence of antigenic shift or 
drift of the virus (2-4).  RSV  infection of human mononuclear leukocytes also 
results in depressed proliferative responses (2), but RSV differs significantly in 
ability to induce production of macrophage-derived immunoregulatory factors, 
such as IFN (2, 5). 
Materials and Methods 
Cell  Collection  and  Separation.  Mononuclear leukocytes were obtained from the pe- 
ripheral blood of healthy adult donors by Ficoll-Hypaque sedimentation, and purified 
monocyte-derived macrophages were obtained by 24-h adherence separation of the cells 
in plastic  culture dishes, as described previously (1,  2).  Such macrophage preparations 
consist  of 93-97%  monocytes-macrophages by strict criteria for differentiation (1,  6). 
Unless noted otherwise, macrophages were cultured at 37°C  in  Eagle's MEM  supple- 
mented with 4% FCS, Hepes buffer, and penicillin (100 U/ml). 
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Exposure  of Cells to Virus, and Collection of Culture Fluids.  Macrophages were exposed 
or sham-exposed for 1 h at 37°C in serum-free medium to influenza A/AA/Marton/43 
H 1N 1, or influenza A/Scotland/840/74  H3N2, or RSV (Long strain), which had been 
grown in allantoic cavities of embryonated hens' eggs or HEp-2 cell cultures, respectively 
(virus/macrophage ratio, 1:1) (2, 5). There were no differences in macrophage interactions 
with  the  different  strains  of influenza  virus.  Macrophages  were  then  cultured  for an 
additional 24 h in medium with 4% FCS, after which supernatant fluids were collected, 
depleted of cells by centrifugation, and stored at -70°C until assayed (7). 
In a subset of experiments, macrophages from which supernatants had been collected 
at  24  h  were  fed  with  fresh  medium, and  supernatants  were again collected at  72  h 
(representing  24-72-h  mediator  production).  Also,  in  another  subset  of experiments, 
concomitant aliquots of the macrophages were exposed to allantoic fluid (without virus), 
LPS (20 ng/ml to 20 ug/ml), from E. coli (Difco Laboratories, Detroit, MI), polymyxin B 
(125-5,000 U/mi), or a combination of polymyxin B with virus or LPS. Polymyxin B was 
added to cultures to diminish any potential contribution of contaminating LPS to results 
observed upon exposure to the virus (8),  although several series of data suggested that 
LPS was highly unlikely to contribute to the results. 
Gel  Filtration.  In  addition  to  measurements of total  (or  net)  activity of the  virus- 
induced  crude  macrophage  culture  supernatant  fluids,  assays  were  performed  using 
components fractionated by Sephadex G-100 column chromatography (9) to characterize 
IL-l-like activity, and to determine whether multiple factors stimulating and inhibiting 
thymocyte proliferation were produced  after exposure to virus.  The void volume was 
determined using blue dextran,  and the  column  was calibrated using several proteins, 
including BSA (66 kD) carbonic anhydrase (29 kD) and cytochrome C (12.4 kD). 
Assays for IL-1  and  IL-I  Inhibitors.  IL-1  activity was  measured  using  the  standard 
mouse thymocyte assay (10). Briefly, 6-8-wk-old C3H/HeJ mice (The Jackson Laboratory, 
Bar Harbor, ME) were killed by cervical dislocation. Using aseptic techniques, the thymus 
glands were removed, teased into single-cell suspensions, and passed through a wire gauge 
to remove particulates, washed twice in PBS, and resuspended in Eagle's MEM supple- 
mented with 4%  FCS,  Hepes buffer, penicillin, and 2-ME (2.5  ×  10 -" M).  Thymocytes 
were cultured for 72 h at  106 cells/well in 96-well flat-bottomed plates (Costar 3596) in 
the  presence  of 5  #g/ml  PHA  and  serial dilutions  of the  test  samples.  Cultures  were 
terminally pulsed with tritiated thymidine, the cells were collected with a semiautomatic 
cell harvester (Brandell Inc., Gaithersburg, MD), and cpm incorporated were determined 
using a liquid scintillation counter. 
The assays for IL-1  incorporated  several relevant controls,  such  as  virus-containing 
culture medium (without cell-derived factors). The viruses, when carried over into mouse 
thymocyte cultures, did not themselves induce proliferation. All assays incorporated (as a 
standard) a purified IL-1 preparation (Ultrapure Interleukin-1; Genzyme, Boston, MA). 
The purified  IL-1  was also used,  in  combination with  test samples in  culture  wells,  in 
assays for IL-1 inhibitors. 
Assays for IL-2 and IL-2 lnhibitors.  Supernatants were tested for IL-2 activity by their 
ability to stimulate the incorporation of tritiated thymidine by IL-2-dependent murine T 
lymphocytes (HT-2), using standard methods (10,11). The incorporated cpm induced by 
dilutions of the various supernatants were compared to cpm induced by standard  IL-2 
preparations, including recombinant DNA-produced IL-2 (Genzyme). The standard IL- 
2 preparations were also used in combination with test supernatants to detect inhibitors 
of IL-2 activity. 
Results 
Supernatant  fluids derived  from human macrophages that  had been exposed 
to influenza virus 24 h  previously contained substantial amounts of IL-1 activity, 
as measured by the standard  mouse thymocyte proliferation assay (Fig.  1).  The 
amount  of IL-1  produced  in  response  to  influenza  virus  was in  excess of that 
induced by as much as 20 ~g/ml of LPS, and was produced despite concomitant ~C)  10 
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FIGURE  1.  IL-I  activity  produced in 24 h by control rnacrophages (M4~) (@) and macrophages 
exposed to influenza virus (ll) or RSV (A). -k, thymocyte proliferation in the absence of 
macrophage fluids. 
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addition  of polymyxin B  (up to 5,000  U/mi) to the cultures  (data not shown). 
Macrophages exposed to virus-free ailantoic  fluid did not produce IL-1.  Unin- 
fected  (control)  macrophages  also  did  not  produce  IL-1,  and  macrophages 
exposed to RSV appeared not to produce IL-1 in the thymocyte comitogen assay 
using crude supernatant fluids (Fig.  1). 
Since  exposure  to either  of the  viruses can  result  in  depressed  lymphocyte 
proliferative responses (2), we next examined whether IL-1  inhibitors might be 
produced  concomitantly  (Fig.  2).  Control  macrophages  did  not produce  IL-1 
inhibitor activity. Overall, there was no net inhibition  of IL-1 activity by super- 
natants  derived  from  influenza  virus-infected  macrophages  at  the  dilutions 
tested.  In  individual  experiments,  however, there was often, at higher  concen- 
trations  of fluid,  inhibition  which could be removed by serial dilution,  leaving 
substantial  residual  IL-1  activity.  In  contrast,  there was marked production  of 
IL-1  inhibitor activity by macrophages exposed to RSV (Fig.  2).  Thus,  experi- 
ments  measuring  activity  of the  crude  supernatant  fluids  did  not  determine 
whether RSV also induced production of IL-1. 
The described effects on thymocyte proliferation did not appear to be due to 
IL-2 or IL-2  inhibitor  activities.  Neither  the  crude  supernatants  from  control 
macrophages  nor those from  macrophages  exposed to influenza  virus or RSV 
contained  IL-2 activity, nor did the  fluids inhibit  IL-2 activity in  the standard 
murine IL-2-dependent lymphocyte proliferation assay (data not shown). 
Supernatant  fluids with macrophage-derived factors produced 24-72  h after 
exposure to influenza virus or RSV showed net IL-1 and IL-1 inhibitor activities 
similar  to  those present  in  the  24-h  fluids (Fig.  3),  although  greater  net  IL-1 
activity appeared to be present in the influenza virus-induced fluids. 
The crude virus-induced macrophage-produced fluids were examined further 
to determine the component activities contributing to the net effects on thymo- 
cyte proliferation described above. Fractions of influenza virus-induced macro- 
phage fluids, separated by Sephadex gel filtration,  were tested for IL-1 activity 
(Fig. 4). The major peak of IL-1 activity eluted at ~14.5 kD, as expected. Such 514  VIRUS-INDUCED  HUMAN  INTERLEUKIN  1  AND  INH1BITORS 
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FIGURE 2.  IL-I inhibitor activity produced in 24 h by control macrophages (O) and macro- 
phages exposed to influenza virus (F-I) or RSV (A). ~, thymocyte proliferation in the presence 
of purified IL-1 in the absence of macrophage fluids. 
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FIGURE  3.  IL-1 (solid line) and 1L-I inhibitor (broken line) activities produced from 24 to 
72 h by macrophages  exposed to influenza virus (I Fq, respectively) or RSV (A, A, respectively). 
×, thymocyte proliferation in the absence of macrophage fluids; *, thymocyte proliferation in 
the presence of purified 1L-1 in the absence of macrophage fluids. 
fractions,  with  substantial  IL-1  activity,  had  no  detectable  IL-2  activity.  An 
additional smaller degree  of IL-l-like  activity eluted at ~81  kD.  The major IL- 
l  activity eluted in fractions without detectable  total protein concentrations. 
The  different  fractions  of  influenza  virus-induced  macrophage  fluids  were 
also  tested  for IL-1  inhibitor activity  (Fig.  5).  Suppression  of thymocyte  prolif- 
eration  in  response  to  IL-1  was  noted  primarily  with  influenza  virus-induced 
fluid fractions of ~99  kD, with a lesser amount of inhibitor activity at ~3-5  kD. 
RSV-induced  macrophage  fluids  were  also  separated  by  gel  filtration  and 
assayed  for  IL-1  activity  (Fig.  6).  The  data  showed  that  RSV  also  induced 
production of IL-1,  undetectable  in the crude supernatant fluids because  of the 
substantial amount of inhibitor activity present.  In fact, since equivalent concen- 
trations of influenza virus- and RSV-induced macrophage fluids were applied to 
the column,  it appeared  that RSV  in fact  induced  IL-1  production to a  degree ROBERTS  ET  AL.  515 
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FIGURE 4.  IL-1  activity in Sephadex gel filtration-separated fractions of fluids derived from 
macrophages exposed to influenza virus. 
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FIGURE 5.  IL-1  inhibitor  activity  in  Sephadex  gel  filtration-separated  fractions  of  fluids 
derived  from  macrophages  exposed  to  influenza  virus.  Activity  is  expressed  as  percent 
suppression relative to responses of thymocytes cultured in the presence of purified I L-1 alone. 
equivalent to that induced by influenza virus. The IL-1  activity of the influenza 
virus-induced  fluids is also shown in Fig. 6  for comparison.  The IL-1  inhibitor 
activity  in  the  fractions of RSV-induced  fluids eluted  with  patterns  similar  to 
those of influenza virus-induce fluids. Furthermore, the higher molecular mass 
inhibitor (99 kD) did not inhibit IL-2 activity. 
Discussion 
These studies suggest that both influenza virus and RSV induce production of 
IL-1  by  human  peripheral  blood-derived  macrophages.  Furthermore,  both 
viruses concomitantly induce production of IL-1 inhibitors. The net macrophage- 
derived mediator activity produced after exposure to influenza virus resulted in 516  VIRUS-INDUCED  HUMAN  INTERLEUKIN  1  AND  INHIBITORS 
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FW.URE 6.  IL-1 activity in Sephadex gel fihration-separated fractions of fluids derived from 
macrophages exposed to influenza virus (11) or RSV (A)- 
enhanced  mouse thymocyte proliferation  in  response to the mitogen  PHA.  In 
contrast,  the net mediator activity produced after exposure to RSV resulted in 
marked  inhibition  of thymocyte proliferation,  either  in  response  to  any  IL-1 
activity that was concurrently produced, or in response to exogenous IL-1 added 
to the cultures. 
The proliferative factors produced in response to the viruses appeared to have 
several of the  characteristics  of IL-1  (9,  12), and  have been  termed  IL-1,  but 
precise  identification  awaits  eventual  sequencing  (as  in  other  such  studies). 
Similarly,  the inhibitors produced in response to the viruses have been termed 
IL-1  inhibitors,  but the exact mechanism(s) of their action are as yet undeter- 
mined.  It does appear  from the current  data  that  the  inhibitors  of thymocyte 
proliferation  do not act by inhibition  of IL-2 activity, nor do they have direct 
cytostatic or cytotoxic effects on the thymocytes (data not shown). It is possible 
that  the  higher  molecular  mass  inhibitor  is  related  to  that  which  others  have 
found to be present  in  the urine of febrile individuals  (13),  but further physi- 
ochemical characterization  would be required to establish such a relationship. 
Viruses have long been considered to be effective inducers of IL-1  (12,  14). 
The  data  regarding  virus-induced  IL-1  production  have  been ahnost  entirely 
derived  from  early  animal  studies.  IL-1  production  was  suggested  by  virus- 
induced fever, mainly in rabbits, wtih assays for circulating endogenous pyrogen 
(15-22), or by measurements of endogenous pyrogen release after exposure of 
rabbit blood cells to virus (23).  Influenza virus was used in many of the animal 
studies. Before our current studies, however, there were no reports of the ability 
of viruses to stimulate human IL-I production in vitro (24). 
We have previously shown (7) that human macrophages exposed to influenza 
virus produce a  soluble fibroblast proliferation-stimulating  factor or factors.  It 
is not yet established whether  the influenza  virus-induced  macrophage  factor, 
or  factors  that  stimulate  fibroblast proliferation  are  the  same as  the  factor(s) 
described in the current studies (putative IL-1  activity), which stimulate mouse 
thymocyte proliferation.  Certainly  the  crude  influenza  virus-induced  macro- 
phage supernatant fluids contain other immunoregulatory proteins as well, such ROBERTS ET  AL.  517 
as IFN (2,  25, 26).  It will be important  to determine  whether the stimulatory 
and  inhibitory  factors described  in  the current  studies  have similar effects on 
human lymphocyte proliferative responses. 
Our  data  suggest that  influenza  virus-induced  depression of human  macro- 
phage accessory cell support for lymphocyte proliferative responses to mitogens 
and antigens (1,  2,  26) is not due to an inability of the infected macrophage to 
produce IL-1.  Thus, the role of the IL-1  inhibitors,  concurrently produced, in 
particular warrant further investigation, including determinations of the effects 
of the mediators on human lymphocyte proliferative responses. Effects on mito- 
gen-stimulated  thymocyte  proliferation,  or  potentially  on  human  lymphocyte 
proliferation, may reflect the total or net activity of numerous composite factors, 
the balance of which, or the precise molecular identity of which, varies according 
to the challenge, (e.g., influenza  virus vs.  RSV). Thus,  these data also raise the 
possibility that one mechanism whereby RSV infection is able to recur frequently 
in supposedly immune individuals is by induction of macrophage-derived factors 
that  suppress  anamnestic  responses  by  host  mononuclear  leukocytes.  Such  a 
possibility also warrants further investigation. 
Summary 
Respiratory  viral  infections  are  commonly  associated  with  altered  immune 
responses, such as proliferative responses to mitogens and antigens. To examine 
potential  mechanisms,  we examined production of IL-1  and  IL-1  inhibitors by 
purified  human  peripheral  blood-derived  macrophages  exposed  to  influenza 
virus or respiratory  syncytial virus (RSV).  IL-1  and  IL-1  inhibitor  activities in 
supernatant  fluids  from  macrophages  exposed to  the  viruses  24  h  previously 
were measured  using  the  standard  mouse thymocyte comitogen  assay.  Crude 
fluids from macrophages exposed to influenza  virus contained substantial  IL-1 
activity,  whereas  crude  fluids  from  macrophages  exposed  to  RSV  contained 
marked  IL-1  inhibitor  activity.  Assays  with  gel  filtration-separated  fractions 
revealed that  both influenza  virus and  RSV induced production  of both  IL-1 
and  IL-1  inhibitors.  Neither  IL-2  nor  IL-2  inhibitor  activities  were detected. 
Thus, effects of human macrophage-derived factors on thymocyte proliferation, 
or potentially on human  lymphocyte proliferation,  may reflect the total or net 
activity of multiple composite factors, the balance of which varies according to 
the  challenge.  The  data  raise  the  possibility that  marked  production  of IL-1 
inhibitor  activity in response to  RSV plays a  role in the clinical  recurrence  of 
RSV infection despite the absence of clear evidence for antigenic  shift or drift 
of tbe virus. 
Received  for publication 28 October 1985. 
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